Browsing: Lilly

Eli Lilly Drugstore LLC (Lilly) and the Department of Health – Abu Dhabi (DoH), regulator of the healthcare sector in Abu Dhabi, have signed a Memorandum of Understanding (MoU) at… The post Lilly and Department of Health – Abu Dhabi Aim to Advance Management of Obesity and Alzheimer’s Disease Through Advanced AI and Clinical Excellence appeared first on Web-Release.

Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced- calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available […] The post FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions appeared first on Web-Release.

Lilly, a leading medicine company, has reached more than 3,000 UAE residents and visitors through a nationwide obesity awareness roadshow, bringing critical information about obesity closer to communities and supporting the UAE’s wider healthcare ambitions. The Lilly Obesity Roadshow made appearances in key healthcare facilities and popular community venues across Abu Dhabi and Dubai, from […] The post Lilly Brings Critical Obesity Information Closer to UAE Community Through Nationwide Awareness Campaign appeared first on Web-Release.